Efficacy and safety of complement inhibitors and FcRn blockers in generalized AChR antibody-positive myasthenia gravis: a meta-analysis
J Neurol. 2026 Apr 2;273(4):244. doi: 10.1007/s00415-026-13778-1. ABSTRACT BACKGROUND: Antibody status is increasingly used to inform treatment strategies in generalized myasthenia gravis (gMG). We evaluated …